Why Fund Managers Love Diageo plc, SABMiller plc And Reckitt Benckiser Group plc

Diageo plc (LON: DGE), SABMiller plc (LON: SAB) and Reckitt Benckiser Group Plc (LON: RB) are three of the most successful companies in the FTSE 100.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

To fund managers, these company names are synonymous with heritage, quality and success. Why does the market rate their shares so highly?

Diageo

Although the corporate entity only came into being in 1996, some of Diageo‘s (LSE: DGE) (NYSE: DEO.US) brands date back to the mid-18th century. These include the J&B whisky range and Guinness. Captain Morgan, Bushmills and Smirnoff are more key brands in the Diageo portfolio.

The worldwide recognition that these products enjoy gives Diageo tremendous pricing power. This feeds back into profits and shareholder dividends.

In the last five years, Diageo has managed to increase operating profits at an average rate of 9.4% a year. Dividend increases have been slightly lower at 6.7% per annum.

For the year ending June 2014, Diageo is expected to report earnings per share (EPS) of 110p and announce total dividends of 51.4p. That puts the shares today on a 2014 P/E of 18.0, with a forecast yield of 2.6%.

SABMiller

Rival brewer SABMiller (LSE: SAB)(NASDAQOTH: SBMRY.US) has a similar scale and global footprint. Key drinks brands in the group are Grolsch, Peroni, Pilsner Urquell and the eponymous Miller. These are must-stock items for off-licences and supermarkets. This helps to protect SAB’s margins, as the company has a strong hand in negotiations.

SABMiller has delivered similar profit growth to Diageo. However, dividend increases have been higher, at an average rate of 11.7% a year for the last five years.

Analysts appear to have more confidence in SABMiller’s future and are predicting superior profit growth to its rival Diageo. Expectations are for a 33% EPS increase this year, followed by another 11% the following year. The shares trade at a small premium to Diageo: 20.8 times forecast profits, with a 2.1% dividend yield expected.

Reckitt Benckiser

Reckitt Benckiser (LSE: RB) owns a collection of food, household products and pharmaceutical brands. Products range from French’s mustard to Calgon and from Harpic to Nurofen. To protect these brands, Reckitt Benckiser invests considerable amounts in advertising. This maintains brand recognition and deters competitors. Any rival would have to match Reckitt’s spend to secure a similar profile.

The result is huge economies of scale and enhanced profit margins.

After five years of increasing EPS by an average of 16.3% per annum, RB is expected to deliver much lower growth over the next two years. The shares are available to buy at 18.0 times 2013 forecast earnings, with an expected yield of 2.9%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> David does not own shares in any of the companies mentioned.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »